Regeneron to Acquire Checkmate Pharmaceuticals and its Inves

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI), a clinical stage biopharmaceutical company focused on proprietary technology to harness the power of the immune system to combat cancer, today announced a definitive agreement for the acquisition of Checkmate by ...

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Rosen Katz , Leonards Schleifer , Regeneron Pharmaceuticals Inc , Checkmate Pharmaceuticals Inc , Lipton , Regeneron Genetics Center , Drug Administration , Goodwin Procter , Nasdaq , Regeneron Pharmaceuticals , Checkmate Pharmaceuticals , Chief Executive Officer , Alan Bash , Art Krieg , Chief Scientific , Hart Scott Rodino Antitrust Improvements Act , Centerview Partners ,